Top

Published in:

Open Access 01-12-2021 | SARS-CoV-2 | Commentary

Commentary: Implications of SARS-Cov-2 infection for pregnancy with diabetes: achievements and open questions for feto-maternal medicine

Authors: Christian S. Göbl, Latife Bozkurt, Wolfgang Henrich

Published in: BMC Pregnancy and Childbirth | Issue 1/2021

Abstract

SARS-Cov-2 (Severe Acute Respiratory Coronavirus 2) infection confers a non-negligible risk for younger pregnant women with diabetes, which is still less well investigated. This topic was recently addressed by a systematic scoping review in BMC Pregnancy and Childbirth, aiming to summarize the complex interaction between SARS-Cov-2 infection, pregnancy and diabetes. This commentary will summarize and discuss the main findings of this article and its implications for future research.

Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8(10):813–22. https://doi.org/10.1016/S2213-8587(20)30272-2.CrossRefPubMedPubMedCentral

Gregory JM, Slaughter JC, Duffus SH, Smith TJ, LeStourgeon LM, Jaser SS, et al. COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic’s impact in type 1 and type 2 diabetes. Diabetes Care. 2021;44(2):526–32. https://doi.org/10.2337/dc20-2260.CrossRefPubMed

Schlesinger S, Neuenschwander M, Lang A, Pafili K, Kuss O, Herder C, et al. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis. Diabetologia. 2021;64(7):1480–91. https://doi.org/10.1007/s00125-021-05458-8.CrossRefPubMedPubMedCentral

Eberle C, James-Todd T, Stichling S. SARS-CoV-2 in diabetic pregnancies: a systematic scoping review. BMC Pregnancy Childbirth. 2021. https://doi.org/10.1186/s12884-021-03975-3.

Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8(9):782–92. https://doi.org/10.1016/S2213-8587(20)30238-2.CrossRefPubMedPubMedCentral

Göbl CS, Bozkurt L, Mittlböck M, Leutner M, Yarragudi R, Tura A, et al. To explain the variation of OGTT dynamics by biological mechanisms: a novel approach based on principal components analysis in women with history of GDM. Am J Phys Regul Integr Comp Phys. 2015;309(1):R13–21. https://doi.org/10.1152/ajpregu.00059.2015.CrossRef

Huhn EA, Rossi SW, Hoesli I, Göbl CS. Controversies in screening and diagnostic criteria for gestational diabetes in early and late pregnancy. Front Endocrinol (Lausanne). 2018;9:696.CrossRef

Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE, et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Diabetes Care. 2012;35(3):526–8. https://doi.org/10.2337/dc11-1641.CrossRefPubMedPubMedCentral

Kotzaeridi G, Blätter J, Eppel D, Rosicky I, Linder T, Geissler F, et al. Characteristics of gestational diabetes subtypes classified by oral glucose tolerance test values. Eur J Clin Investig. 2021;51(9):e13628. https://doi.org/10.1111/eci.13628.CrossRef

10.

Kotzaeridi G, Blätter J, Eppel D, Rosicky I, Mittlböck M, Yerlikaya-Schatten G, et al. Performance of early risk assessment tools to predict the later development of gestational diabetes. Eur J Clin Investig. 2021:e13630. https://doi.org/10.1111/eci.13630. Online ahead of print. PMID: 3414272.

11.

Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017;390(10110):2347–59. https://doi.org/10.1016/S0140-6736(17)32400-5.CrossRefPubMedPubMedCentral

12.

Huhn EA, Linder T, Eppel D, Weißhaupt K, Klapp C, Schellong K, et al. Effectiveness of real-time continuous glucose monitoring to improve glycaemic control and pregnancy outcome in patients with gestational diabetes mellitus: a study protocol for a randomised controlled trial. BMJ Open. 2020;10(11):e040498. https://doi.org/10.1136/bmjopen-2020-040498.CrossRefPubMedPubMedCentral

13.

Chen FC-K, Bacovsky A, Entezami M, Henrich W. Nearly half of all severe fetal anomalies can be detected by first-trimester screening in experts’ hands. J Perinat Med. 2019;47(6):619–24. https://doi.org/10.1515/jpm-2018-0436.CrossRefPubMed

Title: Commentary: Implications of SARS-Cov-2 infection for pregnancy with diabetes: achievements and open questions for feto-maternal medicine
Authors: Christian S. Göbl
Latife Bozkurt
Wolfgang Henrich
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: SARS-CoV-2
COVID-19
Hyperglycemia
Published in: BMC Pregnancy and Childbirth / Issue 1/2021
Electronic ISSN: 1471-2393
DOI: https://doi.org/10.1186/s12884-021-04046-3

2024 ASCO Annual Meeting

Springer Medicine

Commentary: Implications of SARS-Cov-2 infection for pregnancy with diabetes: achievements and open questions for feto-maternal medicine

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

Low-dose aspirin for primary prevention of adverse pregnancy outcomes in twin pregnancies: an observational cohort study based on propensity score matching

Macrosomia is a risk factor for incident maternal chronic kidney disease

Birth companionship in a government health system: a pilot study in Kigoma, Tanzania

Comparative epidemiology of gestational diabetes in ethnic Chinese from Shanghai birth cohort and growing up in Singapore towards healthy outcomes cohort

Prenatal diagnosis of Meier-Gorlin syndrome 7: a case presentation

Optimal outcome factors in maternity and newborn care for inpatient (hospital maternity ward-HMW) and outpatient deliveries (outhospital maternity clinics -OMC)